Skip to main content
. 2020 Sep 3;17(3):791–796. doi: 10.1080/21645515.2020.1802163

Figure 1.

Figure 1.

Percentage of eligible patients that received each vaccine. All patients (n = 502) were eligible for vaccination with Hepatitis B (HepB), Influenza, Pneumococcal Conjugate (PCV13), and Tetanus, Diptheria, with/without acellular pertussis (TDaP/TD) vaccines. The number of eligible patients for other vaccines is as follows: Hepatitis A (HepA): 271; Human Papillomavirus (HPV): 48; Pneumococcal Polysaccharide (PPSV23): 452; Zoster Vaccine Live (ZVL): 70